Sales from the United States contributed nearly 30 billion U.S. dollars towards Pfizer's total revenue in 2021.
Pfizer sees strong growth in emerging markets
Pfizer’s total revenue is divided into four geographic areas: the United States, developed Europe, developed rest of the world, and emerging markets. Strong growth in the emerging markets segment is being driven by China, where sales accounted for a six percent share of Pfizer’s global revenue in 2020. China is one of the company’s largest single markets behind the United States, which contributed over one third of Pfizer’s total revenue. Pfizer continues to support investment in emerging markets, but the vulnerable nature of these countries means strategies come with an element of risk due to unforeseen financial or political events, for example.
The power of product patents
Managing the expiration of key patents is one of the biggest challenges facing Pfizer because competition from generic versions can make a big difference to company revenues. Many of Pfizer’s leading products enjoy the security of market exclusivity, but less expensive generic versions are free to enter the market when these property rights end. In 2019, Pfizer anticipated a fall in sales revenue from China due to significant competition from generic versions.
Pfizer's revenues in global submarkets from 2010 to 2021
(in million U.S. dollars)
This statistic was assembled from several editions of Pfizer's annual financial report.
* Amount reflects the Upjohn Business and the Mylan-Japan collaboration as discontinued operations in all periods presented following the November 16, 2020 spin-off and combination of the Upjohn Business with
Mylan and the December 21, 2020 termination of the Mylan-Japan collaboration. Previous years have not been restated.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Pfizer. (February 24, 2022). Pfizer's revenues in global submarkets from 2010 to 2021 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 19, 2022, from https://www.statista.com/statistics/267877/revenues-of-pfizer-in-submarkets-worldwide/
Pfizer. "Pfizer's revenues in global submarkets from 2010 to 2021 (in million U.S. dollars)." Chart. February 24, 2022. Statista. Accessed May 19, 2022. https://www.statista.com/statistics/267877/revenues-of-pfizer-in-submarkets-worldwide/
Pfizer. (2022). Pfizer's revenues in global submarkets from 2010 to 2021 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 19, 2022. https://www.statista.com/statistics/267877/revenues-of-pfizer-in-submarkets-worldwide/
Pfizer. "Pfizer's Revenues in Global Submarkets from 2010 to 2021 (in Million U.S. Dollars)." Statista, Statista Inc., 24 Feb 2022, https://www.statista.com/statistics/267877/revenues-of-pfizer-in-submarkets-worldwide/
Pfizer, Pfizer's revenues in global submarkets from 2010 to 2021 (in million U.S. dollars) Statista, https://www.statista.com/statistics/267877/revenues-of-pfizer-in-submarkets-worldwide/ (last visited May 19, 2022)